rebif 44mcg/0.5ml s.c. inj. 12 prefilled syringe

Rebif is a medication administered as a subcutaneous injection and contains the active ingredient interferon beta-1A. It is used to help reduce the number of relapses in relapsing multiple sclerosis and to delay the progression of disability.

What are the components of Rebif?

Rebif consists of the following:

• The active ingredient is interferon beta-1A, a genetically engineered protein that resembles the natural proteins produced by the body to fight viruses and regulate the immune system.

Indications for using Rebif

It is used to treat the following conditions:

• Relapsing multiple sclerosis
• Reducing the number of neurological relapses
• Delaying the progression of disability associated with multiple sclerosis

What are the dosages of Rebif?

The dosage is determined according to the condition and includes:

• 22 micrograms / 0.5 ml, three times per week
• 44 micrograms / 0.5 ml, three times per week
• 132 micrograms / 1.5 ml (equivalent to 44 micrograms / 0.5 ml), four cartridges

What are the side effects of Rebif?

It may cause the appearance of some symptoms, including:

• Flu-like symptoms such as fever and headache
• Redness or pain at the injection site
• Changes in liver function
• Depression or mood changes